Health Day - ONLINE EDITION

FDA Approves Hard-to-Abuse Narcotic Painkiller

Targiniq ER contains naloxone, which blunts euphoria of oxycodone when tablet is crushed or broken

  • Print

THURSDAY, July 24, 2014 (HealthDay News) -- A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Called Targiniq ER and made by Purdue Pharma, the pill is a combination of the narcotic oxycodone and naloxone, a drug that blocks the euphoric effects of oxycodone. The naloxone is only activated when the pill is crushed, snorted, dissolved or injected, according to the FDA.

While Targiniq has only been approved for patients who have chronic pain that has not responded to other medications, the FDA acknowledged the medication can still be abused simply by taking too many pills. Currently, that is the most common way oxycodone is misused.

Experts made the same point.

"When the pills are swallowed they are as addictive and dangerous as pure oxycodone," Andrew Kolodny, chief medical officer of the Phoenix House, an alcohol and drug abuse treatment provider, told CNN.

"In a sense it's playing a game of 'whack a mole,' because if people are addicted to opiates, they will find an opiate," Caleb Banta-Green, senior research scientist at the Alcohol and Drug Abuse Institute at the University of Washington, told the news service.

The FDA has come under intense pressure in recent years to restrict the use of narcotic painkillers following reports of escalating painkiller abuse in the United States.

In 2012 alone, 259 million prescriptions were written for powerful painkillers. That's enough for every adult to have their own bottle of pills, U.S. Centers for Disease Control and Prevention officials have said.

And deaths linked to overdoses of narcotic painkillers have quadrupled since 1990, reaching more than 17,000 deaths in 2011, according to the latest CDC estimates.

FDA officials noted Wednesday that approvals of painkillers that are formulated to deter potential abuse are part of a larger effort to curb abuse while still providing some avenue of relief for patients who suffer intense daily pain that does not respond to other medications. In 2010, Purdue Pharma introduced a hard-to-crush version of Oxycontin, and research has shown that abuse of Oxycontin has since decreased, according to CNN.

"The FDA is committed to combating the misuse and abuse of all opioids, and the development of opioids that are harder to abuse is needed in order to help address the public health crisis of prescription drug abuse in the U.S.," Dr. Sharon Hertz, deputy director of the division of anesthesia, analgesia and addiction products in the FDA's Center for Drug Evaluation and Research, said in an agency news release.

Targiniq's approval was based on the results of a study that involved more than 600 patients struggling with lower back pain, the agency said. The medication proved to be both safe and effective, with the most common side effect being nausea and vomiting.

Still, the FDA will require Purdue Pharma to conduct further studies to monitor any abuse of the drug.

More information

For more on opioids and chronic pain, visit the U.S. National Institutes of Health.

Fact Check

Fact Check

Have you found an error, or know of something we’ve missed in one of our stories?
Please use the form below and let us know.

* Required
  • Please post the headline of the story or the title of the video with the error.

  • Please post exactly what was wrong with the story.

  • Please indicate your source for the correct information.

  • Yes

    No

  • This will only be used to contact you if we have a question about your submission, it will not be used to identify you or be published.

  • Cancel

Having problems with the form?

Contact Us Directly
  • Print

You can comment on most stories on winnipegfreepress.com. You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.

You can comment on most stories on winnipegfreepress.com. You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.

Have Your Say

New to commenting? Check out our Frequently Asked Questions.

Have Your Say

Comments are open to Winnipeg Free Press print or e-edition subscribers only. why?

Have Your Say

Comments are open to Winnipeg Free Press Subscribers only. why?

The Winnipeg Free Press does not necessarily endorse any of the views posted. By submitting your comment, you agree to our Terms and Conditions. These terms were revised effective April 16, 2010.

letters

Make text: Larger | Smaller

LATEST VIDEO

Winnipeg Cheapskate: Home buying

View more like this

Photo Store Gallery

  • A Canada Goose cools off in a water pond Monday afternoon at Brookside Cemetary- See Bryksa’s Goose a day Challenge– Day 27-June 25, 2012   (JOE BRYKSA / WINNIPEG FREE PRESS)
  • An American White Pelican takes flight from the banks of the Red River in Lockport, MB. A group of pelicans is referred to as a ‘pod’ and the American White Pelican is the only pelican species to have a horn on its bill. May 16, 2012. SARAH O. SWENSON / WINNIPEG FREE PRESS

View More Gallery Photos

Poll

Do you think volunteers dragging the Red River is a good idea?

View Results

Ads by Google